A New Epigenetic Switch for Early Embryonic Development

For decades, scientists have been unraveling the intricate mechanisms that govern gene expression. While DNA methylation has long been recognized as a key player in this process, recent discoveries have unveiled a new player: 5-formylcytosine (5fC). This novel epigenetic modification has the potential to reshape our understanding of early development and disease.

A team of researchers led by Professor Christof Niehrs at the Institute of Molecular Biology (IMB) in Mainz, Germany, has made a groundbreaking discovery. Published in the journal Cell, they have demonstrated for the first time that 5fC acts as an activating epigenetic switch that initiates gene expression during early embryonic development. This finding challenges the traditional view of epigenetic regulation, which has primarily focused on the role of DNA methylation in gene silencing.

A single fertilized egg cell, the starting point for a complex organism, undergoes rapid cell division and differentiation. This process is orchestrated by epigenetic modifications like DNA methylation and histone modifications, which alter chromatin structure and accessibility, thereby influencing gene activity and guiding cell fate. These epigenetic modifications, acting as molecular switches, turn precise genes “on” or “off,” shaping the organism’s development.

In previous blog posts, we have discussed how researchers have been investigating epigenetics to unravel the details of the connection between epigenetics and embryo development. We have also discussed the biological importance of DNA methylation and how 5fC is a DNA demethylation intermediate that can reverse the effects of gene silencing from DNA methylation.

Now, Niehrs and his team have demonstrated that one of these modifications, 5fC, plays a role in activating genes during early development. This breakthrough proves that vertebrates have multiple types of epigenetic DNA marks and unveils a new mechanism for regulating gene expression.

“These findings are a real breakthrough in epigenetics,” says Niehrs, “because 5fC is only the second proven epigenetic DNA modification besides methylcytosine.

The team studied 5fC in frog embryos using microscopy and chromatography techniques. They discovered a significant increase in 5fC levels at the onset of development, particularly during zygotic activation, when many genes are activated.

Observing 5fC in microscopically visible tiny dots, known as chromocenters, was an exciting discovery for Eleftheria Parasyraki, the study’s first author. This finding prompted the team to suspect that 5fC plays a crucial role in early embryonic development.

The researchers confirmed 5fC as an activating epigenetic mark by genetically modifying enzymes in frog embryos to adjust 5fC levels on the DNA. Elevated 5fC levels led to increased gene expression, while reduced levels suppressed it, demonstrating its role in gene activation. Additionally, the discovery of similar 5fC chromocenters during zygotic gene activation in mouse embryos highlights a conserved function for 5fC as an activating regulator across vertebrates, including both mammals and frogs.

This discovery opens up important questions regarding the role of 5fC beyond early development, particularly given its elevated levels in cancer cells. Further research is necessary to fully understand its function, which could offer valuable insights into gene regulation during development and its potential disruption in disease.

Source: Parasyraki, Eleftheria et al. 5-Formylcytosine is an activating epigenetic mark for RNA Pol III during zygotic reprogramming. Cell (October 17, 2024).

Resource: Johannes Gutenberg Universitaet Mainz. Scientists find new epigenetic switch: 5-formylcytosine activates genes in the embryonic development of vertebrates. 18 September 2024.

Related Articles

WIE-logo-icon

If you like reading our articles…

Join our e-newsletter! Stay up-to-date with our weekly posts on epigenetics and health, nutrition, exercise, and more.